| Views | |
|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 101 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 0 | 14 | 7 | 3 | 2 | 11 | 0 |
| Views | |
|---|---|
| 2023_Kreye_etal.pdf | 36 |
